COVID-19: Vaccines and Therapeutics
The American Medical Association published a Current Procedural Terminology code for providers administering a potential third dose of the current Pfizer COVID-19 vaccine.
The Centers for Disease Control and Prevention released a study confirming the comparative effectiveness of COVID-19 vaccines versus natural immunity, including immunity gained from prior SARS-CoV-2 infection.
The AHA launched a video encouraging families with children 12 and older to add COVID-19 vaccinations to their back-to-school preparations.
In a large clinical trial, treating hospitalized COVID-19 patients who did not require organ support with a full-dose blood thinner reduced the need for organ support, such as mechanical ventilation, and helped them leave the hospital, the National Institutes of Health reported.
Moderna Inc. announced during an investors report that its COVID-19 vaccine remains 93% effective through the first six months following a full dosing regimen
The World Health Organization, citing worldwide disparities in COVID-19 vaccination rates, urged the wealthiest nations to free up vaccine supply by refraining from administering boosters.
AHA statement on FY 2022 final IPPS rule from Executive Vice President Stacey Hughes.
The Food and Drug Administration authorized using the monoclonal antibody therapy REGEN-COV for prevention in certain children and adults who are not fully vaccinated against COVID-19 or not expected to mount an adequate immune response to vaccination.
The American Hospital Association and its Society for Healthcare Strategy and Market Development (SHSMD) July 15 hosted “Addressing COVID-19 Vaccine Hesitancy in Your Community,” a webinar centered on examining the root causes of vaccine hesitancy and how health care organizations can tailor their…
Read a recap and insights from health care leaders during AHA’s July 15 webinar, “Addressing COVID-19 Vaccine Hesitancy in Your Community,” featuring messaging points tailored to specific communities and key lessons from a Kaiser Permanente study.